Ionising Radiation Protection

2021 ◽  
pp. 423-445
Author(s):  
Cornelius Lewis ◽  
Jim Thurston
2012 ◽  
Vol 41 (3-4) ◽  
pp. 305-312
Author(s):  
K.R. Kase

The International Radiation Protection Association (IRPA) has a membership of approximately 17,000 individuals who are members of 48 national societies in 60 countries worldwide. As such, IRPA's vision is to be recognised as the international voice of the radiation protection professional. This article will discuss elements of the outcome of the 12th International Congress of IRPA (‘Focus on the future’), objectives and current activities of IRPA, criteria and priorities for the engagement of IRPA with international organisations, current IRPA initiatives in the areas of radiation protection culture and certification/qualification of radiation protection experts, planning for the 13th International Congress of IRPA, comments on the implementation of recent recommendations of the International Commission on Radiological Protection (ICRP), and suggestions about IRPA and ICRP collaboration in their implementation. IRPA recognises that ICRP is the international body to determine policy and to make recommendations for protection against ionising radiation, and IRPA is in a position to participate in and facilitate the implementation of those recommendations.


2020 ◽  
Vol 49 (1_suppl) ◽  
pp. 158-168
Author(s):  
N.E. Martinez ◽  
L. Van Bladel

As we work towards a holistic approach to radiation protection, we begin to consider and integrate protection beyond humans to include, among other things, non-human biota. Non-human biota not only includes environmental flora and fauna, but also livestock, companion animals, working animals, etc. Although under consideration, there is currently little guidance in terms of protection strategies for types of non-human biota beyond wildlife. For example, in recent years, veterinary procedures that make use of ionising radiation have increased in number and have diversified considerably, which has made radiation protection in veterinary applications of ionising radiation more challenging, both for humans and the animal patients. In fact, the common belief that doses to professionals and members of the public from these applications will be very low to negligible, and doses to the animals will not be acutely harmful nor even affect their lifetime probability of developing cancer, needs to be revisited in the light of higher dose diagnostic and interventional techniques, and certainly in the case of therapeutic applications. This paper provides a brief overview of the initiatives of the International Commission on Radiological Protection concerning radiation protection aspects of veterinary practice, and poses a variety of perspectives for consideration and further discussion.


2018 ◽  
Vol 47 (3-4) ◽  
pp. 152-158 ◽  
Author(s):  
C. Hoeschen

While many areas of radiation protection have formed so-called ‘platforms’ in Europe which provide strategic research agendas for their areas of interest, this did not happen for a long while for medical exposure, which is the application of ionising radiation that causes the greatest man-made exposure, at least in first world countries. Finally, in 2015, a European medical radiation protection strategic research agenda was set up, and a corresponding platform was launched in 2016. This was named ‘EURAMED’ – the European Alliance for Medical Radiation Protection Research. In its strategic research agenda, EURAMED defined its vision for medical radiation protection and the corresponding research needed. Five major topics were identified, ranging from measurements of medical application-related parameters such as exposures and image quality and radiation biology aspects relevant for medical applications to individual optimisation strategies, to optimal use of techniques and harmonisation of practises, and finally to justification of the use of ionising radiation in medicine, all based on sufficient infrastructures for quality assurance. The ultimate goal is to reduce radiation exposure and risk individually for patients and staff by interdisciplinary research between clinicians, physicists, and engineers. Therefore, it is essential that the results are translated into clinical practice.


Author(s):  
Thomas Otto

AbstractThis chapter treats hazards originating from particle beams. The interaction of charged particle beams with matter is described. Beam loss can cause material damage in structural and electronic components. Ionising radiation is introduced by a description of the different types of radiation. Then, the sources of ionising radiation at accelerators are defined: beam loss is the origin of prompt ionising radiation. Material activated by the passage of particle cascades is a long-lived source of ionising radiation. The chapter is closed with a description of radiation dosimetry and radiation protection at accelerators.


Sign in / Sign up

Export Citation Format

Share Document